Latde Diagnostics Corp.

Northampton, MA

UEI
NGM2X9P8A9J3
CAGE
95PY0
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
30 Woodbine Ave, Northampton, MA 01060, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Rapid, equitable, lateral flow-based antibiotic susceptibility testing for urinary tract infections R43AI186702 National Institute of Allergy and Infectious Diseases (NIH) $843,538

Grant subawards

Prime recipient Prime award Amount Awarded
Cornell University The goal of the project is to Validate a rapid instrument-free antibiotic susceptibility test (AST) for urinary tract infections (UTI) in clinical urine samples… U54EB034654 $99,990

Quick answers

Is Latde Diagnostics Corp. registered in SAM.gov?

Yes. Latde Diagnostics Corp.'s SAM.gov registration is active through March 25, 2027.

What is Latde Diagnostics Corp.'s CAGE code?

Latde Diagnostics Corp.'s CAGE code is 95PY0, and its Unique Entity ID (UEI) is NGM2X9P8A9J3.

What is Latde Diagnostics Corp.'s most recent federal award?

Latde Diagnostics Corp.'s most recent federal grant award is Rapid, equitable, lateral flow-based antibiotic susceptibility testing for urinary tract infections (R43AI186702), from National Institute of Allergy and Infectious Diseases (NIH), on July 8, 2024.

On GovTribe

See Latde Diagnostics Corp.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login

Find teaming partners on GovTribe